News

A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.

UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.

Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.

Read about a new study which highlights the needs to increase support for stroke survivors

UCL and UCLH researchers have developed an artificial intelligence-based tool that can assess a patient’s brain tumour scan and provide greater patient-personalised detail to aid their treatment.

Cervical cancer patients are significantly more likely to be alive and cancer-free after five years when given a short course of chemotherapy prior to chemoradiation, finds a clinical trial led by researchers from UCL and UCLH.

UCLH is one of 13 NHS hospitals running a world-leading study in which hundreds of babies will be tested for over 200 rare genetic conditions. The pioneering study aims to screen up to 100,000 newborns in England.

More than 400 patients at UCLH have so far benefited from an exciting new cancer treatment called proton beam therapy (PBT) – which uses high-energy beams of protons, rather than X-rays, to deliver a dose of radiotherapy.

A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.

A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.